Somatus Manages Over 500,000 Patients Nationwide
Somatus has announced in a press release that it now manages over 500,000 patients across all 50 states and DC. The company, known for its value-based, specialist-led primary care management, has expanded its capabilities to include congestive heart failure care management, commercial self-insured populations, and AI-driven disease identification and payment integrity services.
Somatus has achieved significant growth through existing customer expansions, new client launches, and enhanced capabilities. The company manages over $14 billion in healthcare costs and maintains a 100% customer and provider partner retention rate for 2024 and 2025. This growth reflects the increasing demand for Somatus' integrated care model, which supports patients with kidney disease, congestive heart failure, and other complex conditions.
The company has also reported impressive clinical outcomes, including a 28% improvement in blood pressure control rates and a 48% higher home dialysis start rate compared to national benchmarks. Somatus continues to advance its clinical and technological capabilities, focusing on early-stage disease identification through AI and predictive analytics, and contracting with over 100 nephrology practices and 5,500 providers nationwide.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 30 Insilico Medicine Selects AI Designed Obesity Drug Candidate ISM1354 Sep 29 Truven launches MarketScan Snapshot for healthcare data checks Sep 29 Omega Healthcare Wins Gold in 2026 AI Breakthrough Awards Sep 29 Phylo Launches Target Atlas for Drug Target Prioritization Sep 29 ChromAgeNet Detects Aging Signs in Blood Stem Cell ImagesLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Atman Health Wins ARPA-H Award to Build Heart Failure AI
SENA Health Raises Series A for AI Care Coordination
Ayble Health Raises $16 Million for Virtual Digestive Care
Nuna Health Offers Eligible Medicare Beneficiaries Free AI Health Coaching
DarioHealth Wins Contract With Major New Jersey Health Plan
Daily AI Brief: the AI news that matters, in your inbox.